Theresa M Busch1. 1. Department of Radiation Oncology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6072, USA. buschtm@mail.med.upenn.edu
Abstract
BACKGROUND AND OBJECTIVE: Herein an overview is provided of the causes, consequences, and significance of photodynamic therapy (PDT)-mediated effects on tumor oxygenation and blood flow during illumination. STUDY DESIGN/ MATERIALS AND METHODS: Techniques particularly valuable to this research have included tissue oxygen tension measurement by the Eppendorf pO2 Histograph; spatial quantification of hypoxia by EF3 and EF5; and tissue oxygenation/blood flow monitoring by diffuse reflectance/correlation spectroscopy. RESULTS: Severe hypoxia was measured in vivo during PDT and is shown to be a consequence of photochemical oxygen consumption and/or compromised vascular perfusion. Oxygen depletion can be controlled by treatment regimen, occurs in a spatially-definable pattern, and is therapy-limiting. PDT-induced changes in tumor oxygenation during illumination are correlated with outcome. In PDT-treated tissues, blood flow also is determined by treatment regimen and correlates with treatment response. CONCLUSIONS: Photodynamic therapy creates distinct, measurable changes in tumor oxygen and blood flow during illumination. These physiological changes may ultimately affect treatment efficacy. Copyright 2006 Wiley-Liss, Inc.
BACKGROUND AND OBJECTIVE: Herein an overview is provided of the causes, consequences, and significance of photodynamic therapy (PDT)-mediated effects on tumor oxygenation and blood flow during illumination. STUDY DESIGN/ MATERIALS AND METHODS: Techniques particularly valuable to this research have included tissue oxygen tension measurement by the Eppendorf pO2 Histograph; spatial quantification of hypoxia by EF3 and EF5; and tissue oxygenation/blood flow monitoring by diffuse reflectance/correlation spectroscopy. RESULTS: Severe hypoxia was measured in vivo during PDT and is shown to be a consequence of photochemical oxygen consumption and/or compromised vascular perfusion. Oxygen depletion can be controlled by treatment regimen, occurs in a spatially-definable pattern, and is therapy-limiting. PDT-induced changes in tumor oxygenation during illumination are correlated with outcome. In PDT-treated tissues, blood flow also is determined by treatment regimen and correlates with treatment response. CONCLUSIONS: Photodynamic therapy creates distinct, measurable changes in tumoroxygen and blood flow during illumination. These physiological changes may ultimately affect treatment efficacy. Copyright 2006 Wiley-Liss, Inc.
Authors: Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan Journal: Chem Rev Date: 2010-05-12 Impact factor: 60.622
Authors: Patrycja Mikolajewska; Ryan F Donnelly; Martin J Garland; Desmond I J Morrow; Thakur Raghu Raj Singh; Vladimir Iani; Johan Moan; Asta Juzeniene Journal: Pharm Res Date: 2010-07-31 Impact factor: 4.200
Authors: Shannon M Gallagher-Colombo; Harry Quon; Kelly M Malloy; Peter H Ahn; Keith A Cengel; Charles B Simone; Ara A Chalian; Bert W O'Malley; Gregory S Weinstein; Timothy C Zhu; Mary E Putt; Jarod C Finlay; Theresa M Busch Journal: Photochem Photobiol Date: 2015-07-02 Impact factor: 3.421
Authors: Peter H Ahn; Jarod C Finlay; Shannon M Gallagher-Colombo; Harry Quon; Bert W O'Malley; Gregory S Weinstein; Ara Chalian; Kelly Malloy; Thomas Sollecito; Martin Greenberg; Charles B Simone; Sally McNulty; Alexander Lin; Timothy C Zhu; Virginia Livolsi; Michael Feldman; Rosemarie Mick; Keith A Cengel; Theresa M Busch Journal: Photodiagnosis Photodyn Ther Date: 2017-11-04 Impact factor: 3.631